News Detail

Cambridge, 5 Nov 2023: A cancer drug in the final stages of clinical trials may be able to help treat a range of inflammatory diseases including gout, heart failure, cardiomyopathy, and atrial fibrillation, according to scientists at the University of Cambridge.
Source : Genetic Engineering and Biotechnology News
Anti cancer drugs
Atrial fibrillation
Cardiomyopathies
Gout
Heart failure
Immune response
Immune system diseases
Mitosis
Phase III clinical trials (Clinical trial)
Related News
- IIT Madras Patents Drug Delivery System For Breast Cancer Treatment (13-02-2025)
- IIT Roorkee Scientists Uncover Superbug’s Defense Mechanism (12-02-2025)
- Solving the drug solubility problem with silica nanoparticles (10-02-2025)
- Revolutionary new cancer treatment destroys tumors in less than 6 days (10-02-2025)
- Nanoparticles damage coronavirus, paving the way for new disinfection technology (02-02-2025)
- Oxford Researchers Develop Method To Identify Fake Covid-19 Vaccines (01-02-2025)
- New drug candidate shows potential to restore vision in people with MS (27-01-2025)
- Researchers pinpoint keys to cell therapy response for leukemia (27-01-2025)
- Research could lead to better medicines and new tools in synthetic biology (25-01-2025)
- Scientists design peptides to enhance drug efficacy (25-01-2025)